|
GB202102666D0
|
|
Pbp3 binding bicyclic peptide ligands
|
|
GB202101613D0
|
|
Bicyclic peptide ligands specific for human plasma kallkrein
|
|
WO2021064428A1
|
|
Heterotandem bicyclic peptide complexes
|
|
GB202015663D0
|
|
Bicyclic peptide ligand drug conjugates
|
|
WO2021028686A1
|
|
Modified multimeric bicyclic peptide ligands
|
|
US2021040154A1
|
|
Heterotandem bicyclic peptide complex
|
|
WO2020225577A1
|
|
Bicyclic peptide ligands specific for ox40
|
|
GB202006485D0
|
|
Anti-infective bicyclic peptide conjugates
|
|
WO2020201753A1
|
|
Bicycle toxin conjugates and uses thereof
|
|
GB202003982D0
|
|
Pbp3 binding bicyclic peptide ligards
|
|
GB202002705D0
|
|
Anti-infective bicyclic peptide conjugates
|
|
GB202002706D0
|
|
Pbp3 binding bicyclic peptide ligands
|
|
GB202002708D0
|
|
Bicyclic peptide ligands specific for il-17
|
|
WO2020165600A1
|
|
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
GB202001591D0
|
|
Bicyclic peptide ligands specific for human plasma kallikrein
|
|
US2021101932A1
|
|
Bicyclic peptide ligands specific for pd-l1
|
|
GB201918510D0
|
|
Bicycle peptide ligands specific for IL-17
|
|
WO2020120984A1
|
|
Bicyclic peptide ligands specific for mt1-mmp
|
|
WO2020084305A1
|
|
Bicyclic peptide ligands and uses thereof
|
|
GB201914872D0
|
|
Bicyclic peptide ligand drug conjugates
|
